Switching Immunosuppressants May Reduce Cancer Risk in Kidney Transplant ... - Renal and Urology News PDF Print
Renal and Urology News“This is the first randomized, controlled trial to address whether patients treated with mTOR inhibitors after renal transplantation have less skin cancer,” ...Converting to Sirolimus From Calcineurin Inhibitors Reduces Risk of Skin

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.